Inogen (INGN) EBT Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.82% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 32.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 61.06% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.57% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 14.40% |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 25.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.01% |
| Dec 31, 2025 | -31.30% |
| Sep 30, 2025 | 16.77% |
| Jun 30, 2025 | -8.47% |
| Mar 31, 2025 | 23.47% |
| Dec 31, 2024 | 42.53% |
| Sep 30, 2024 | -44.59% |
| Jun 30, 2024 | -35.11% |
| Mar 31, 2024 | -83.46% |
| Dec 31, 2023 | -73.29% |
| Sep 30, 2023 | -187.20% |
| Jun 30, 2023 | -68.40% |
| Mar 31, 2023 | -128.60% |
| Dec 31, 2022 | 104.86% |
| Sep 30, 2022 | -45.46% |
| Jun 30, 2022 | -30.97% |
| Mar 31, 2022 | -62.66% |
| Dec 31, 2021 | -65.00% |
| Sep 30, 2021 | -19.34% |
| Jun 30, 2021 | -4.18% |
| Mar 31, 2021 | -30.96% |
| Dec 31, 2020 | -42.58% |
| Sep 30, 2020 | -30.39% |
| Jun 30, 2020 | -27.28% |
| Mar 31, 2020 | -31.75% |
| Dec 31, 2019 | -39.70% |
| Sep 30, 2019 | 17.12% |
| Jun 30, 2019 | 19.38% |
| Mar 31, 2019 | 21.33% |
| Dec 31, 2018 | 20.63% |
| Sep 30, 2018 | 45.37% |
| Jun 30, 2018 | 36.94% |
| Mar 31, 2018 | 58.82% |
| Dec 31, 2017 | 63.04% |
| Sep 30, 2017 | 36.41% |
| Jun 30, 2017 | 34.39% |
| Mar 31, 2017 | 58.91% |
| Dec 31, 2016 | 192.55% |
| Sep 30, 2016 | 88.23% |
| Jun 30, 2016 | 58.05% |
| Mar 31, 2016 | 64.70% |